Notice
3 Jul 2025
healthcare, investment, nih, technology transfer, patent licensing, autoimmune diseases, commercial opportunities, biopharma
đź’ŠExclusive Patent License Notice for CAR Technology by NIH
The National Cancer Institute, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the patents applications listed in the Supplementary Information section of this notice to Capstan Therapeutics, Inc. (Capstan), a company located in San Diego, California, the United States of America.
Learn More